眼胶质淋巴系统及相关眼病研究进展

doi:10.12114/j.issn.1007-9572.2022.0901

摘要/Abstract

摘要： 最近发现的眼胶质淋巴系统更新了临床对眼内循环的认知，其是一个由神经胶质细胞终足上水通道蛋白4（AQP4）驱动并依赖视网膜动、静脉周围间隙的房水-组织液交换系统，最终起到将β淀粉样蛋白等神经毒性物质排出眼外的作用。本文综述了眼胶质淋巴系统的组成和功能，描述了生理状态下该系统具体的循环路径及其在青光眼、视盘水肿、Terson综合征（TS）等疾病过程中的障碍机制，并提出未来可确定眼胶质淋巴系统具体调控环节，针对具体环节改善该系统的功能，如利用中药多靶点、多途径的优势促进眼内代谢废物的清除，这将有机会为青光眼等诸多眼病和一些中枢神经系统疾病的治疗带来希望。

关键词: 神经胶细胞类淋巴系统, 眼胶质淋巴系统, 青光眼, 视盘水肿, Terson综合征, 综述

Abstract:

Recent discovered ocular glymphatic system, which is facilitated by aquaporin-4 (AQP4) and dependent on the exchange system of aqueous humor-tissue fluid in the perivascular space of retinal arterial and venous, ultimately acts as the role of expelling neurotoxic substances such as beta-amyloid out of the eye, has updated our knowledge of intraocular circulation. This paper reviews the composition and function of ocular glymphatic system, describes its specific circulatory paths in the physiological state and mechanism of impairment in the progression of glaucoma, optic disc edema, Terson syndrome and other diseases, In the future, we can identify the specific regulatory links of the ocular glymphatic system and improve the function of the system, such as using the advantages of multiple targets and multiple pathways of traditional Chinese medicine to promote the removal of metabolic wastes in the eye, which will bring hope to the treatment of many eye diseases such as glaucoma and some central nervous system diseases.

Key words: Glymphatic system, Ocular glymphatic system, Glaucoma, Optic disk edema, Terson syndrome, Review

祝光宇,程雨欣,路雪婧. 眼胶质淋巴系统及相关眼病研究进展[J]. 中国全科医学, 2023, 26(26): 3330-3334. DOI: 10.12114/j.issn.1007-9572.2022.0901.
ZHU Guangyu,CHENG Yuxin,LU Xuejing. Research Progress of Ocular Glymphatic System and Related Ocular Diseases[J]. Chinese General Practice, 2023, 26(26): 3330-3334. DOI: 10.12114/j.issn.1007-9572.2022.0901.

参考文献 52

[1]	CASSON R J，CHIDLOW G，CROWSTON J G，et al. Retinal energy metabolism in health and glaucoma[J]. Prog Retin Eye Res，2021，81：100881. DOI：10.1016/j.preteyeres.2020.100881.
[2]	WANG X W，LOU N H，EBERHARDT A，et al. An ocular glymphatic clearance system removes β-amyloid from the rodent eye[J]. Sci Transl Med，2020，12（536）：eaaw3210. DOI：10.1126/scitranslmed.aaw3210.
[3]	Archiv für pathologische anatomie und physiologie und für klinische medicin[J]. Br Foreign Med Chir Rev，1861，27（53）：52-65.
[4]	ILIFF J J，WANG M H，LIAO Y H，et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes，including amyloid Β[J]. Sci Transl Med，2012，4（147）：147ra111. DOI：10.1126/scitranslmed.3003748.
[5]	LOUVEAU A，SMIRNOV I，KEYES T J，et al. Structural and functional features of central nervous system lymphatic vessels[J]. Nature，2015，523（7560）：337-341. DOI：10.1038/nature14432.
[6]	RASMUSSEN M K，MESTRE H，NEDERGAARD M. Fluid transport in the brain[J]. Physiol Rev，2022，102（2）：1025-1151. DOI：10.1152/physrev.00031.2020.
[7]	PLOG B A，NEDERGAARD M. The glymphatic system in central nervous system health and disease：past，present，and future[J]. Annu Rev Pathol Mech Dis，2018，13：379-394. DOI：10.1146/annurev-pathol-051217-111018.
[8]	HABLITZ L M，PLÁ V，GIANNETTO M，et al. Circadian control of brain glymphatic and lymphatic fluid flow[J]. Nat Commun，2020，11（1）：4411. DOI：10.1038/s41467-020-18115-2.
[9]	NEDERGAARD M，GOLDMAN S A. Glymphatic failure as a final common pathway to dementia[J]. Science，2020，370（6512）：50-56. DOI：10.1126/science.abb8739.
[10]	TOH C H，SIOW T Y. Glymphatic dysfunction in patients with ischemic stroke[J]. Front Aging Neurosci，2021，13：756249. DOI：10.3389/fnagi.2021.756249.
[11]	SULLAN M J，ASKEN B M，JAFFEE M S，et al. Glymphatic system disruption as a mediator of brain trauma and chronic traumatic encephalopathy[J]. Neurosci Biobehav Rev，2018，84：316-324. DOI：10.1016/j.neubiorev.2017.08.016.
[12]	BAE Y J，CHOI B S，KIM J M，et al. Altered glymphatic system in idiopathic normal pressure hydrocephalus[J]. Parkinsonism Relat Disord，2021，82：56-60. DOI：10.1016/j.parkreldis.2020.11.009.
[13]	DENNISTON A K，KEANE P A. Paravascular pathways in the eye：is there an'ocular glymphatic system'?[J]. Invest Ophthalmol Vis Sci，2015，56（6）：3955-3956. DOI：10.1167/iovs.15-17243.
[14]	WOSTYN P，DE GROOT V，VAN DAM D，et al. The glymphatic system：a new player in ocular diseases?[J]. Invest Ophthalmol Vis Sci，2016，57（13）：5426-5427. DOI：10.1167/iovs.16-20262.
[15]	TAM A L C，GUPTA N，ZHANG Z X，et al. Quantum dots trace lymphatic drainage from the mouse eye[J]. Nanotechnology，2011，22（42）：425101. DOI：10.1088/0957-4484/22/42/425101.
[16]	MATHIEU E，GUPTA N，MACDONALD R L，et al. In vivo imaging of lymphatic drainage of cerebrospinal fluid in mouse[J]. Fluids Barriers CNS，2013，10（1）：35. DOI：10.1186/2045-8118-10-35.
[17]	WOSTYN P，KILLER H E，DE DEYN P P. Glymphatic stasis at the site of the lamina cribrosa as a potential mechanism underlying open-angle glaucoma[J]. Clin Exp Ophthalmol，2017，45（5）：539-547. DOI：10.1111/ceo.12915.
[18]	MATHIEU E，GUPTA N，AHARI A，et al. Evidence for cerebrospinal fluid entry into the optic nerve via a glymphatic pathway[J]. Invest Ophthalmol Vis Sci，2017，58（11）：4784-4791. DOI：10.1167/iovs.17-22290.
[19]	JACOBSEN H H，RINGSTAD G，JØRSTAD Ø K，et al. The human visual pathway communicates directly with the subarachnoid space[J]. Invest Ophthalmol Vis Sci，2019，60（7）：2773-2780. DOI：10.1167/iovs.19-26997.
[20]	WOSTYN P，DE GROOT V，VAN DAM D，et al. The first histologic evidence of a paravascular pathway within the optic nerve[J]. Invest Ophthalmol Vis Sci，2018，59（5）：1717. DOI：10.1167/iovs.17-23119.
[21]	UDDIN N，RUTAR M. Ocular lymphatic and glymphatic systems：implications for retinal health and disease[J]. Int J Mol Sci，2022，23（17）：10139. DOI：10.3390/ijms231710139.
[22]	MOGENSEN F L H，DELLE C，NEDERGAARD M. The glymphatic system（En）during inflammation[J]. Int J Mol Sci，2021，22（14）：7491. DOI：10.3390/ijms22147491.
[23]	WANG R，SEIFERT P，JAKOBS T C. Astrocytes in the optic nerve head of glaucomatous mice display a characteristic reactive phenotype[J]. Invest Ophthalmol Vis Sci，2017，58（2）：924-932. DOI：10.1167/iovs.16-20571.
[24]	SIMONS E S，SMITH M A，DENGLER-CRISH C M，et al. Retinal ganglion cell loss and gliosis in the retinofugal projection following intravitreal exposure to amyloid-beta[J]. Neurobiol Dis，2021，147：105146. DOI：10.1016/j.nbd.2020.105146.
[25]	NIZARI S，GUO L，DAVIS B M，et al. Non-amyloidogenic effects of α2 adrenergic agonists：implications for brimonidine-mediated neuroprotection[J]. Cell Death Dis，2016，7（12）：e2514. DOI：10.1038/cddis.2016.397.
[26]	XIN S H，TAN L，CAO X P，et al. Clearance of amyloid beta and tau in alzheimer's disease：from mechanisms to therapy[J]. Neurotox Res，2018，34（3）：733-748. DOI：10.1007/s12640-018-9895-1.
[27]	MATHIEU E，GUPTA N，PACZKA-GIORGI L A，et al. Reduced cerebrospinal fluid inflow to the optic nerve in Glaucoma[J]. Invest Ophthalmol Vis Sci，2018，59（15）：5876-5884. DOI：10.1167/iovs.18-24521.
[28]	RANGROO THRANE V，HYNNEKLEIV L，WANG X W，et al. Twists and turns of ocular glymphatic clearance-new study reveals surprising findings in glaucoma[J]. Acta Ophthalmol，2021，99（2）：e283-284. DOI：10.1111/aos.14524.
[29]	BANEKE A J，AUBRY J，VISWANATHAN A C，et al. The role of intracranial pressure in glaucoma and therapeutic implications[J]. Eye（Lond），2020，34（1）：178-191. DOI：10.1038/s41433-019-0681-y.
[30]	LIU H R，YANG D Y，MA T，et al. Measurement and associations of the optic nerve subarachnoid space in normal tension and primary open-angle Glaucoma[J]. Am J Ophthalmol，2018，186：128-137. DOI：10.1016/j.ajo.2017.11.024.
[31]	MAO Y Y，YANG D Y，LI J，et al. Finite element analysis of trans-lamina cribrosa pressure difference on optic nerve head biomechanics：the Beijing Intracranial and Intraocular Pressure Study[J]. Sci China Life Sci，2020，63（12）：1887-1894. DOI：10.1007/s11427-018-1585-8.
[32]	VILLARRUEL J M，LI X Q，BACH-HOLM D，et al. Anterior Lamina cribrosa surface position in idiopathic intracranial hypertension and glaucoma[J]. Eur J Ophthalmol，2017，27（1）：55-61. DOI：10.5301/ejo.5000806.
[33]	KIM J A，KIM T W，LEE E J，et al. Comparison of lamina cribrosa morphology in eyes with ocular hypertension and normal-tension Glaucoma[J]. Invest Ophthalmol Vis Sci，2020，61（4）：4. DOI：10.1167/iovs.61.4.4.
[34]	WOSTYN P，GIBSON C R，MADER T H. The odyssey of the ocular and cerebrospinal fluids during a mission to Mars：the ocular glymphatic system under pressure[J]. Eye（Lond），2022，36（4）：686-691. DOI：10.1038/s41433-021-01721-9.
[35]	LEE A G，MADER T H，GIBSON C R，et al. Space flight-associated neuro-ocular syndrome（SANS）[J]. Eye（Lond），2018，32（7）：1164-1167. DOI：10.1038/s41433-018-0070-y.
[36]	WOSTYN P，DE WINNE F，STERN C，et al. Potential involvement of the ocular glymphatic system in optic disc edema in astronauts[J]. Aerosp Med Hum Perform，2020，91（12）：975-977. DOI：10.3357/AMHP.5670.2020.
[37]	WOSTYN P，DE WINNE F，STERN C，et al. Dilated prelaminar paravascular spaces as a possible mechanism for optic disc edema in astronauts[J]. Aerosp Med Hum Perform，2018，89（12）：1089-1091. DOI：10.3357/AMHP.5095.2018.
[38]	LAWLEY J S，PETERSEN L G，HOWDEN E J，et al. Effect of gravity and microgravity on intracranial pressure[J]. J Physiol，2017，595（6）：2115-2127. DOI：10.1113/JP273557.
[39]	MACIAS B R，PATEL N B，GIBSON C R，et al. Association of long-duration spaceflight with anterior and posterior ocular structure changes in astronauts and their recovery[J]. JAMA Ophthalmol，2020，138（5）：553-559. DOI：10.1001/jamaophthalmol.2020.0673.
[40]	BARISANO G，SEPEHRBAND F，COLLINS H R，et al. The effect of prolonged spaceflight on cerebrospinal fluid and perivascular spaces of astronauts and cosmonauts[J]. Proc Natl Acad Sci U S A，2022，119（17）：e2120439119. DOI：10.1073/pnas.2120439119.
[41]	HUPFELD K E，RICHMOND S B，MCGREGOR H R，et al. Longitudinal MRI-visible perivascular space（PVS）changes with long-duration spaceflight[J]. Sci Rep，2022，12（1）：7238. DOI：10.1038/s41598-022-11593-y.
[42]	KUMARIA A，GRUENER A M，DOW G R，et al. An explanation for Terson syndrome at last：the glymphatic reflux theory[J]. J Neurol，2022，269（3）：1264-1271. DOI：10.1007/s00415-021-10686-4.
[43]	KUMARIA A，GRUENER A M，LENTHALL R K，et al. Terson syndrome in reverse：intraventricular haemorrhage following primary intraocular haemorrhage[J]. Neurol Sci，2022，43（7）：4551-4553. DOI：10.1007/s10072-022-06053-4.
[44]	GAUNTT C D，SHERRY R G，KANNAN C. Terson syndrome with bilateral optic nerve sheath hemorrhage[J]. J Neuroophthalmol，2007，27（3）：193-194. DOI：10.1097/WNO.0b013e31814b22dc.
[45]	KO F，KNOX D L. The ocular pathology of Terson's syndrome[J]. Ophthalmology，2010，117（7）：1423-1429.e2. DOI：10.1016/j.ophtha.2009.11.028.
[46]	SAKAMOTO M，NAKAMURA K，SHIBATA M，et al. Magnetic resonance imaging findings of Terson's syndrome suggesting a possible vitreous hemorrhage mechanism[J]. Jpn J Ophthalmol，2010，54（2）：135-139. DOI：10.1007/s10384-009-0783-3.
[47]	IULIANO L，FOGLIATO G，CODENOTTI M. Intrasurgical imaging of subinternal limiting membrane blood diffusion in terson syndrome[J]. Case Rep Ophthalmol Med，2014，2014：689793. DOI：10.1155/2014/689793.
[48]	KUMARIA A，GRUENER A M，LENTHALL R K，et al. Terson syndrome in reverse：intraventricular haemorrhage following primary intraocular haemorrhage[J]. Neurol Sci，2022，43（7）：4551-4553. DOI：10.1007/s10072-022-06053-4.
[49]	ANDERSON D R. Ultrastructure of human and monkey lamina cribrosa and optic nerve head[J]. Arch Ophthalmol，1969，82（6）：800-814. DOI：10.1001/archopht.1969.00990020792015.
[50]	ANDERSON D R，HOYT W F. Ultrastructure of intraorbital portion of human and monkey optic nerve[J]. Arch Ophthalmol，1969，82（4）：506-530. DOI：10.1001/archopht.1969.00990020508017.
[51]	ASHOK A，SINGH N，CHAUDHARY S，et al. Retinal degeneration and alzheimer's disease：an evolving link[J]. Int J Mol Sci，2020，21（19）：7290. DOI：10.3390/ijms21197290.
[52]	KRESS B T，ILIFF J J，XIA M S，et al. Impairment of paravascular clearance pathways in the aging brain[J]. Ann Neurol，2014，76（6）：845-861. DOI：10.1002/ana.24271.